目的：介绍肝癌门静脉癌栓激光联合光敏剂治疗的方法，并探讨这一治疗方法的安全性和有效性。
Objective:To introduce a new therapy combining percutaneous laser and photosensitizer in treatment of portal vein tumor thrombus(PVTT), and evaluate the efficacy and validity of the method.
其中门静脉癌栓的形成，肝内及远处的侵袭转移是肝癌治疗效果差，病情进展快的重要原因。
Including the formation of portal vein tumor thrombus, intrahepatic and distant metastasis is poor liver cancer treatment, rapid progression of the major reasons.
放射介入栓塞化疗对肝癌合并门静脉癌栓治疗的疗效观察。
Transcatheter arterial chemoembolization therapy in the treatment of hepatocellular carcinoma with tumor thrombus of portal vein.
目的：探讨螺旋CT肝双期扫描对原发性肝癌门静脉、肝静脉及下腔静脉癌栓的诊断价值。
Objective: to discuss the value of spiral ct dual phase scanning for diagnosis of tumor thrombosis of venous system of hepatocellular carcinoma.
目的：探讨门静脉癌栓及其栓塞的程度对原发性肝癌的血供的影响。
Objective: To investigate the effect of portal venous cancerous embolism and its degree of embolism on the blood supply of primary hepatic carcinoma (pHC).
目的探讨肝癌合并门静脉癌栓的手术疗效，评价术中门静脉癌栓取出术和术后辅助肝动脉栓塞化疗对提高肝癌术后生存率的影响。
Objective To explore the value of removing portal vein tumor thrombus (PVTT) and TACE in improving the outcome of resection for primary liver cancer with PVTT.
结果：有28例发现肝脏灌注异常影像表现（21.1%，28/133），以原发性肝细胞癌为多见（22.5%，20/89），尤其是合并门静脉癌栓的肝癌病例（46.2%，12/26）。
Results:28 cases were found to have hepatic perfusion disorders(21.1%, 28/133). The common cause was HCC(22.5%, 20/89), especially HCC with portal vein tumor thrombus(46.2%, 12/26).
结果：有28例发现肝脏灌注异常影像表现（21.1%，28/133），以原发性肝细胞癌为多见（22.5%，20/89），尤其是合并门静脉癌栓的肝癌病例（46.2%，12/26）。
Results:28 cases were found to have hepatic perfusion disorders(21.1%, 28/133). The common cause was HCC(22.5%, 20/89), especially HCC with portal vein tumor thrombus(46.2%, 12/26).
应用推荐